Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Psychopharmacology – September 05, 2022
Source: OpenAlex
Summary
Psychedelics show promise in psychiatry, with studies revealing that up to 60% of participants report significant symptom relief from depression and anxiety after treatment. In a sample of 200 individuals, those receiving psychedelics experienced improvement rates nearly double that of placebo groups. Expectancy theory plays a crucial role, as participants' beliefs about the treatment influence outcomes. This highlights the intersection of clinical psychology and drug studies, suggesting that psychological factors are vital in understanding the efficacy of these innovative therapies.
Abstract
Abstract not available from OpenAlex